Reduction of gastrointestinal symptoms in Parkinson's disease after a switch from oral therapy to rotigotine transdermal patch: A non-interventional prospective multicenter trial

Abstract Introduction Gastrointestinal (GI) symptoms are common among patients with Parkinson's disease (PD), due to both the disease itself and anti-PD drugs. We hypothesized that transdermal drug administration may result in fewer GI problems. This prospective observational study (ClinicalTri...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Parkinsonism & related disorders 2015-03, Vol.21 (3), p.199-204
Hauptverfasser:	Woitalla, Dirk, Kassubek, Jan, Timmermann, Lars, Lauterbach, Thomas, Berkels, Reinhard, Grieger, Frank, Müller, Thomas
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Aged Aged, 80 and over Antiparkinson Agents - administration & dosage Dopamine agonist Female Follow-Up Studies Gastrointestinal Gastrointestinal Diseases - drug therapy Gastrointestinal Diseases - etiology Humans Male Middle Aged Neurology Non-motor Pain Measurement Parkinson Disease - complications Parkinson Disease - drug therapy Parkinson's disease Patient Satisfaction Rotigotine Tetrahydronaphthalenes - administration & dosage Thiophenes - administration & dosage Transdermal Patch
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!